Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane-bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers. uPAR levels, however, d
Expression and significance of urokinase-type plasminogen activator in breast cancer
β Scribed by Xiao Jiping; Zhang Guangde; Xia Wenhua
- Book ID
- 107467144
- Publisher
- Chinese Anti-Cancer Association
- Year
- 1999
- Tongue
- English
- Weight
- 247 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The involvement of the urokinaseβtype plasminogen activator (uPA) system in particular has been extensively studied in the pathogenesis of cancer. The molecular role of the uPA receptor (uPAR) is well characterized with its participation in cell migration and extracellular matrix (ECM)
Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.
## Background and objectives: Urokinase type plasminogen activator (upa) regulates a variety of processes involved in tissue morphogenesis, cell differentiation, migration and invasion. we analyzed the available informations to better interpret the pathogenetic relationship between upa activity and